🇺🇸

US SEC Filing Intelligence

· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 19, 2026

This Activist & Institutional Activity digest covers 50 SEC filings dated October 19, 2026, almost all of them routine Schedule 13G/13D disclosures for the 2026-10-19 reporting window. The population is dominated by passive institutional holders: First Trust entities filed roughly 20 joint 13G/As on ETFs, UITs and closed-end vehicles, AIGH Capital (Hirschman) filed a cluster of 13Gs on micro-cap biotech and tech names, and Pzena and Truist filed a series of passive positions. Genuine event-driven activism is concentrated in a small number of 13D/As: Glenbrook Capital's public campaign at SenesTech (38.04% stake, $4.33M of purchases in Oct 15-19, dilution-focused letter), BW Group exiting Navigator Holdings (sold ~3.1M shares over ~3 weeks, now below 5%), United Refining's open-market accumulation of 1stdibs.com (~7.8%), and insider-controlled 13D/As at JX Luxventure (CEO at 25.61% after a 1,000,000-share grant) and Karbon-X. Sell-side and quantitative period-over-period comparisons were not supplied for most filings, so the trend analysis below is limited to the explicit share-count, percentage and transaction data in the filings. The ETF/fund-sponsor filings are high-volume but low-information, and the most actionable items are SenesTech, Navigator, 1stdibs, JX Luxventure and BayFirst.

7 high priority 43 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 19, 2026

Insider and 10b5-1 selling dominated the 2026-10-19 filings across the S&P 500 Financials constituents in scope: all seven filings are Form 4 disclosures, and six of seven carry negative or neutral sentiment with no period-over-period, guidance, capital allocation, or M&A data provided in the enriched payloads. The largest dollar flow was Japan Post Holdings' ~$13.4M of AFLAC sales across three tranches, a 10% holder reducing exposure rather than an insider signaling views on operations. Bank of America's CEO disposed of 18,083 shares at $51.70 (~$935K) to the issuer, which appears tied to tax withholding on vested RSUs rather than open-market conviction, leaving him with 2.70M shares. Capital One's two executives sold near-identical share counts at $195.86 under 10b5-1 plans, a pattern consistent with pre-scheduled liquidity rather than new information. Mastercard's CFO exercised options and sold 4,317 shares at $620 (~$2.68M), the largest executive sale in the set, and was executed under a 10b5-1 plan. Robinhood Ventures Fund I's 10% owner Robinhood Markets sold ~11.6K shares across two tranches at $25.16-$25.55. BlackRock's principal accounting officer disposed of 1,192 shares with no pricing disclosed. Overall the batch offers little fundamental read-through; the actionable signal is concentration of supply in AFLAC and sizing of routine executive selling.

7 high priority 7 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 19, 2026

Three filings were published in the Energy stream for 2026-10-19, but the data is thin: one insider Form 4 (EXPAND ENERGY, small tax withholding, neutral), one material 8-K (EXPAND ENERGY CEO succession, positive, materiality 7/10), and one routine Form 4 (ONEOK RSU award, neutral). The dominant development is Expand Energy's leadership transition: Daniel E. Brown takes over as President and CEO effective October 26, 2026, replacing interim CEO Michael A. Wichterich, who returns to Non-Executive Chairman. The filings supply no period-over-period financials, forward guidance, capital allocation changes, or M&A terms, so the analysis cannot identify sector-level margin or growth trends from this batch. Insider activity is routine (tax withholding and scheduled equity grants) and does not signal management conviction in either direction. The key market implication is that Expand Energy's strategic direction may shift under Brown, whose Chord Energy track record centers on portfolio transformation; investors should monitor for guidance or capital allocation changes after the October 26 effective date.

3 high priority 3 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 19, 2026

This stream contains a single enriched filing: a Form 4 from a 10% owner, the Hershey Trust Co trustee for the Milton Hershey School, disclosing eight open-market sales of Hershey (HSY) common stock at prices between roughly $167 and $171 per share, totaling about $1.27M in the reported transactions. The seller retains 566,119 shares after the transaction, and the sales were executed under a Rule 10b5-1 plan, which reduces the signal value of the trades since they were pre-scheduled rather than discretionary. No period-over-period financial comparisons, forward-looking guidance, capital allocation changes, M&A activity, or scheduled events were included in the enriched data, so portfolio-level trend analysis across companies is not possible from this stream. The one material observation is a steady, systematic divestment by a large holder at stable price levels, which is consistent with a diversification or funding program rather than a reaction to company-specific news. Because the enriched sentiment is negative and materiality is only 5/10, the filing is best treated as a monitoring item rather than a actionable trading catalyst.

1 high priority 1 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 19, 2026

The stream covers 25 SEC filings dated 2026-10-19, but only 3M (8-K) falls within the S&P 500 Industrials scope; the remaining 24 filings are Form 4 insider transactions from REPUBLIC SERVICES, INC. (waste management, which sits in Industrials under GICS but was not confirmed as a constituent in this stream's fixed 33-identifier list, so it is treated cautiously). The enriched period-over-period, financial ratio, and forward-looking fields are not populated in the filing summaries provided, so no YoY/QoQ trend analysis can be quantified from this batch. The dominant development is 3M's expanded commercial relationship with an Amazon subsidiary, which includes a seven-year warrant for up to 3,162,015 shares at $164.89 tied to $6 billion in cumulative data center payments, a material but unquantified commercial event. The Republic Services filings reflect routine, uniform director and executive equity grants at a common $229.65 price, with no open-market purchases or sales, signalling no notable management conviction shift. Overall, the batch is thin on investable signal and heavy on routine compensation disclosure.

24 high priority 1 medium 25 total filings
· daily

US Material Events SEC 8-K Filings — October 19, 2026

Across 50 SEC filings dated October 19, 2026, the dominant theme is capital structure activity: refinancings (Integra, Enerpac, Chefs' Warehouse, Vail, FrontView), equity raises and dilutive private placements (Curis, OS Therapies, Glucotrack, Dogwood, Agassi Sports), and large M&A (Tradeweb-Trumid at ~$1.97B, Centrus-Westerman at ~$116M, TCGX-TriGemX SPAC at ~$246M gross proceeds). Governance churn is widespread, with CFO transitions at Torrid, JELD-WEN, Lear, CRISPR, and CarMax, plus board resignations at Polomar, Apogee, Omnitek, and Professional Diversity Network. Quantitative period-over-period data is sparse: only Rocky Mountain Chocolate Factory provides a full YoY/QoQ set, showing revenue down ~2.5% YoY, a six-month net loss nearly tripling to $2.4M, cash falling to $416K, and current liabilities at $13.6M. Chord Energy is the main positive operating datapoint, with volumes above guidance and $205MM of 3Q26 buybacks. Distress is concentrated in Cambium Networks' UK insolvency sale, Apogee's restatement, and micro-cap financing stress. Market-implication weight rests on Tradeweb, Rocky Mountain Chocolate's strategic review, and ZoomInfo's $44M settlement.

50 high priority 50 total filings
· daily

Insider Trading Pulse — October 19, 2026

Across the 50 Form 4 filings dated 2026-10-19, insider activity is dominated by routine equity compensation (RSU, PSU and restricted share awards at PDF Solutions, Sterling Real Estate Trust, Tencent Music, Ingredion and Flex) and tax-withholding dispositions at Standard Nuclear, which together account for the majority of filings and carry limited directional signal. The genuinely discretionary open-market activity is concentrated in a small set of names: Applied Digital (President Zhang bought ~$5.66M and CEO Cummins bought ~$1.01M), FingerMotion (CEO and CFO small-lot purchases), Agora (CEO buying under a 10b5-1 plan) and Elite Pharmaceuticals (director purchase of ~$26K). Sales are modest in aggregate and mostly executed under Rule 10b5-1 plans, including Ciena (CEO, ~$1.03M), Teradyne (CEO ~$1.37M and director ~$273K), Nebius (director ~$181K) and Global-E (president ~$282K across three tranches). The filings do not contain period-over-period financial comparisons, forward guidance or capital allocation data, so trend and valuation conclusions must be inferred from transaction prices and holdings only, and this digest should be read as a directional insider-sentiment screen rather than a fundamentals review. Several filings are pure administrative events (gifts, withholdings, director fee awards) with no market signal.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 19, 2026

Four SEC filings dated 2026-10-19 were reviewed for the USA Dow Jones 30 stream. Three filings are in scope: 3M (8-K announcing an expanded strategic commercial relationship with an Amazon subsidiary, including a seven-year warrant for up to 3,162,015 shares at $164.89 tied to cumulative Amazon payments reaching $6 billion) and two Apple Inc. Form 4 insider filings. The Walt Disney filing is also an insider Form 4 for an in-scope Dow constituent and is therefore retained. The enriched data supplied for these filings does not include quantified period-over-period comparisons, forward-looking guidance, or capital allocation changes, so trend analysis is limited; the 3M filing explicitly contains no financial results or dilution quantification. The dominant theme is insider selling clustered at Apple (CFO and Principal Accounting Officer) and Disney (EVP Control, Fin Plan & Tax), with the majority of sales executed under Rule 10b5-1 plans, which reduces their signal value. The most materially market-relevant development is 3M's Amazon warrant, which signals a large data-center-linked commercial commitment whose financial impact remains unquantified and warrants follow-up disclosure.

1 high priority 3 medium 4 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 19, 2026

Both filings in this distress-focused stream point to acute stress among small-cap US issuers, though the severity differs sharply. Stardust Power (SDST) has crossed a hard Nasdaq trigger: its stock closed at $0.10 or less for ten consecutive trading days, leading to suspension and delisting of both common stock and warrants at the open on October 23, 2026, with a hearing request (fee $20,000, deadline 4:00 p.m. ET, October 23) that will not stay the suspension. Its CFO has resigned effective the same date, and the board is weighing headcount cuts, possible suspension of SEC reporting, and a sale or merger, with no assurance of any outcome. Scienture Holdings reported preliminary unaudited Q3 2026 revenue of about $1.22 million, up 256% sequentially from roughly $344,000 in Q2, on the August 2026 REZENOPY launch and Arbli wholesale unit growth of 74% sequentially, but its own risk factors flag going-concern doubt, dilution, lender security interests, and Nasdaq listing risk. The portfolio pattern is a steep sequential revenue inflection at a company that still lacks audited results and profitability, versus an outright exchange-driven delisting at another. Because the Scienture figures are unaudited and subject to adjustment in the 10-Q, the growth story should be discounted until verified. The key near-term market event is the October 23 Stardust delisting cascade, which is largely determined by the exchange rule rather than management action.

2 high priority 2 total filings
· daily

Global High-Priority Regulatory Events — October 19, 2026

Across the 50 filings for the Global High Priority Market Events stream (period 2026-10-19), the dominant themes are distressed situations and corporate control transactions. Insolvency and delisting events cluster heavily: Dharan Infra-EPC's CIRP continues after NCLT rejected a creditor settlement-based withdrawal, Sun Granite is extending its resolution expression-of-interest window, Cambium Networks' UK unit is being sold out of administration, and Stardust Power faces accelerated Nasdaq delisting with its CFO departing. Several US delistings (Atkore post-Prysmian merger, Voya EM High Dividend fund, Algoma warrants) reflect completed reorganizations rather than distress. Control and restructuring activity is elevated: mandatory and voluntary open offers (Kuber Udyog, RR Metalmakers, Genomic Valley, Inani Securities, Oxford Industries), the PFC-REC merger clearing exchange observation letters, the Eaton/Dana Mobility combination, and SPAC business combinations (TCGX). Period-over-period data is thin in the enriched fields, but the few quantified results are weak: Rocky Mountain Chocolate's current liabilities nearly doubled and cash fell to $416K, while Scienture's Q3 revenue rose 256% QoQ from a small base. Management and sponsor activity points to balance-sheet stress in micro-cap issuers and pending-regulatory-approval risk in large mergers.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 19, 2026

The October 19, 2026 digest covers a broad mix of 50 SEC filings dominated by foreign private issuer 6-K press-release wrappers whose substance sits in unseen exhibits, alongside 13F and 13G ownership disclosures, Form 4 insider transactions, proxy materials, and a handful of material corporate events. The most market-moving items are the Synaptics all-cash $123.00 per-share merger with onsemi (valued at a 22% premium, 10/10 materiality, with a competing Party A stock-based proposal creating valuation tension), Fifth Third Bancorp's Q3 2026 print (adjusted EPS $1.13 versus reported $0.90, with net interest income up 49% YoY on the Comerica acquisition but noninterest expense up 62% YoY), and Atlantic American's FY2025 10-K/A showing revenue up 11.9% to $210.4M and net income swinging to $6.0M from a $1.4M loss. Governance and restatement risk is elevated in the SPAC cluster: Apogee Acquisition Corp disclosed Q2 2026 restatement affecting trust contributions and redeemable share classification, with a director and COO departing, while Archimedes Tech SPAC II shareholders approved the Forge Nano combination but with notable dissent (about 2.07M AGAINST on charter proposals). Insider activity was light and mostly routine (director RSU and share awards at Flex, Tencent Music and Tesla-adjacent boards), with the open-market buys at Elite Pharmaceuticals ($26K at $0.26) and FingerMotion (CEO and CFO small purchases) the only clear conviction signals. Quarterly period-over-period comparisons were absent for most 13F and 6-K filings, so portfolio-level margin and growth trends are only assessable for the bank and insurer filings.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 19, 2026

All five filings are Tesla, Inc. (TSLA) SEC proxy and solicitation materials dated October 19, 2026, tied to the December 3, 2026 Annual Meeting; they fall within the Consumer Discretionary automotive scope and are therefore retained. The filings contain no reported financial results, period-over-period revenue or margin data, insider transactions, capital allocation actions, or M&A activity, so the enriched financial fields are largely empty and the analysis is governance- and event-driven rather than fundamental. The dominant theme is governance friction: a 2025 shareholder proposal to eliminate supermajority voting failed with roughly 39.4% support despite 73.6% participation, the Board has declined to repropose it, and the company has tightened CEO and insider stock-pledging limits. Management is simultaneously pushing shareholder turnout through a new Voluntary Retail Voting Program and a campaign to re-elect Elon Musk, Robyn Denholm and JB Straubel, while citing operating milestones (over 10 million vehicles delivered, 130+ GWh energy storage deployed, ~1.5 million paid FSD customers, Robotaxi in seven U.S. cities). The market implication is that the December 3 vote and the director re-elections are the key near-term event, and any dissent on the Musk slate or the compensation vote would be a governance signal rather than a financial one.

1 high priority 4 medium 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 19, 2026

The five filings in this S&P 500 Healthcare stream are a thin, mostly routine set: one material corporate event (Medtronic's completed MiniMed separation via exchange offer), two small Vertex director equity grants, a Cigna 13F holdings report, and a Lilly Endowment 13G/A ownership update. No period-over-period financial metrics, guidance changes, capital allocation figures, or M&A valuations were supplied in the enriched data for these filings, so portfolio-level trend analysis (growth rates, margin shifts) cannot be credibly drawn; we flag this as a data limitation rather than inferring trends. The most consequential development is Medtronic's exit from its remaining MiniMed stake, which removes a legacy holding overhang and completes a separation intended to be tax-free to shareholders. Insider activity is limited to routine, non-discretionary director compensation at Vertex, which carries no conviction signal. Institutional ownership disclosures (Cigna 13F, Lilly Endowment 13G/A) are informational and do not indicate a directional change in positioning. Overall, the period reads as a low-conviction, housekeeping-heavy stream with one notable corporate action.

3 high priority 2 medium 5 total filings
· daily

US Earnings Financial Results SEC Filings — October 19, 2026

Two Q3/Q2 2026 SEC 10-Q filings were reviewed under the Financial Results & Earnings stream, and they diverge sharply. Fastenal (FAST) delivered broad-based growth, with Q3 2026 net sales up 15.5% YoY to $2,463.3M and nine-month net income up 16.6% to $1,124.2M, though cash fell to $211.9M as trade receivables rose $369.9M since year-end 2025, absorbing $379.1M of operating cash. Rocky Mountain Chocolate Factory (RMCF) shows deteriorating fundamentals: Q2 FY2027 net loss widened to $1,281K from $662K, six-month losses more than doubled to $2,449K, quarterly revenue fell 2.5%, and franchise/royalty fees dropped 18.2%. The most material development is RMCF's reclassification of $6,780K of notes payable to current, which against only $416K of cash creates a near-term refinancing or maturity risk. Read together, the period comparisons point to a bifurcation between a scaled, growing distributor with healthy top-line momentum and a small-cap consumer name facing liquidity pressure. Insider activity and forward-looking guidance were not provided in either enriched filing, so conviction signals rest on reported financials alone.

2 high priority 2 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 19, 2026

This Executive Compensation Insights digest covers 18 DEF 14A and DEFM14A filings dated around October 19, 2026, but the stream is themed on executive pay, governance, and shareholder proposals, and most filings in this batch are dominated by transaction, financing, or extension votes rather than compensation disclosure. The most material development is Synaptics' all-cash $123.00 per share merger with onsemi (22% premium, 23.5x NTM non-GAAP P/E), where the board itself concedes that a competing stock-based Party A proposal could carry higher implied value. Dilution and capital-structure votes are the dominant theme: Summit Therapeutics seeks to double authorized common stock to fund a $2.0B AstraZeneca preferred placement, Future FinTech seeks a roughly 96-fold authorized share increase, and FTC Solar and Crexendo seek equity issuance and plan-capacity approvals. Several SPAC and micro-cap filers (Aimei Health, Kochav Defense) are seeking extensions that carry redemption and dilution risk to public holders, while Tesla's proxy highlights governance friction after a failed supermajority-elimination vote with 39.4% support. Period-over-period figures are largely absent from this batch, so the quantitative read is limited to disclosed capital structure, valuation, and fee data rather than YoY performance trends.

18 high priority 18 total filings
· daily

US IPO Pipeline SEC S-1 Filings — October 19, 2026

This IPO Pipeline stream covers four US SEC registration filings dated October 19, 2026, but the enriched data is thin: the two Mobility (USA) Corp S-4 filings are substantive, while the AIAI Holdings and Star Equity Holdings excerpts are almost entirely XBRL metadata with no readable offering terms, financials, or deal consideration. The dominant development is the Eaton-Dana Mobility spin-off and two-step merger (Merger Agreement dated June 10, 2026), which pairs a 9/10 materiality transaction with clear execution risk: a $158.7 million potential termination fee, unresolved permanent debt financing against bridge facilities, and multiple closing conditions including HSR clearance, NYSE listing, and Dana stockholder approval. Dana's ongoing buybacks (8,036,601 shares for about $242.0 million against a roughly $300.0 million target) increase the SpinCo Cash Payment by an estimated $301.2 million and raise combined-company leverage, so the capital structure is still moving. No period-over-period revenue, margin, or ratio data is present in the filings provided, so portfolio-level growth or margin trends cannot be quantified from this set. The AIAI Holdings and Star Equity filings should be treated as registration placeholders pending fuller excerpts rather than actionable IPO candidates.

4 high priority 4 total filings
· daily

US SEC Trading Suspension Halt Orders — October 19, 2026

The USA Trading Suspensions stream for 2026-10-19 contains two filings, and only one is squarely in scope. Stardust Power (SDST) is the core event: a Nasdaq Staff Determination triggered by ten consecutive trading days at or below $0.10 mandates suspension and delisting of both common stock and warrants at the open on October 23, 2026, with a hearing request (fee $20,000, deadline 4:00 p.m. ET October 23) that will not stay the suspension. Compounding the event are the CFO's resignation effective October 23, a board exploring headcount cuts, possible suspension of SEC reporting, and strategic alternatives with no assurance of success. Scienture Holdings (8-K) is a mixed-sentiment filing: preliminary unaudited Q3 2026 revenue of about $1.22 million rose 256% from roughly $344,000 in Q2 2026 on the REZENOPY launch and Arbli wholesale unit growth of 74% sequentially, but it carries going-concern language and an explicit Nasdaq listing risk under Item 3.01, so it sits adjacent to the delisting theme rather than as a completed event. Enriched period-over-period data for Stardust is limited to the compliance-deadline timeline rather than financial trends, and the market value of listed securities deficiency (April 24, 2026 notice, October 21, 2026 deadline) shows the company was failing multiple Nasdaq standards before the bid-price trigger. Overall the stream's theme is listing-standard failure leading to forced delisting, with the Scienture revenue inflection being the one counter-signal, though preliminary and unaudited.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — October 19, 2026

Across the 36 filings, the dominant theme is executive and director turnover concentrated in finance leadership: at least eight CFO or principal financial officer transitions (JELD-WEN, Standex, Mattel, Lear, Matrix Service, CRISPR, Torrid, CytoDyn/Home Bancorp-style interim arrangements, Medtronic-adjacent governance) reflect a broad rotation of finance talent, with several interim arrangements signalling incomplete searches. Board additions skew toward experienced operators and capital-markets executives (Tammy Fischer at Acadia, Kyle Crowley at ProPetro, Lynn Martin at Williams-Sonoma, John Frederick at Tempest, Scott Morris at Once Upon a Farm), which the filings frame as supporting capital discipline and growth. Quantitative period-over-period data is largely absent from this stream: most 8-Ks are governance announcements without financial results, so portfolio-level growth and margin trends can be measured only for the few filings that report results (Chord Energy, Home Bancorp, Venu, JELD-WEN guidance). Where results exist the picture is mixed: Chord Energy beat volume guidance and repurchased $205MM of stock, while Home Bancorp's net income fell about 13% QoQ, NIM compressed 5 bps to 4.19%, and nonperforming assets rose 37%. Several negative governance signals stand out, notably Polomar's board shrinking to three directors with committee vacancies, Professional Diversity Network and Omnitek director resignations, and BNB Standard/CEA Industries operating with interim leadership and a material weakness. The most market-relevant developments are the Expand Energy CEO appointment (Daniel Brown, effective October 26), the CRISPR CFO promotion with a pending Prasad exit, and the Medtronic/MiniMed separation completion.

36 high priority 36 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 19, 2026

Across the 36 filings in the USA Board Room Changes stream (all dated 2026-10-19 window), the dominant theme is a heavy wave of CFO and finance-leadership turnover: at least eight companies (JELD-WEN, Standex, CRISPR, Torrid, Matrix Service, Mattel, CarMax, Lear, CytoDyn, NRC Health) announced CFO or principal financial officer changes, several involving interim arrangements or overlapping transitions. Board additions dominate the rest, with a notable cluster of ex-CFOs and finance executives joining boards (Skillsoft, Exelon, Freshpet, Deloitte, ICE/NYSE). Most leadership changes are described as orderly, with no disagreement cited, though several resignations (Polomar, Professional Diversity Network, Omnitek) leave committee or board-size gaps. The filings provided largely lack quantitative period-over-period data, so trend analysis is limited; where figures exist, Home Bancorp shows deteriorating credit quality (nonperforming assets up 37% QoQ) and Chord Energy shows volume beats with $205MM of buybacks, while Medtronic completed the MiniMed separation. Market implication: finance-function transitions at mid-cap industrials and consumer names warrant monitoring for reporting continuity during year-end close.

36 high priority 36 total filings
· daily

USA Insider Trading Pulse — October 19, 2026

This digest covers 50 SEC Section 16 style insider filings dated 2026-10-19 across a broad mix of issuers. The dominant pattern is compensation-driven activity: the majority of filings are equity awards (RSUs, PSUs, restricted shares, phantom stock), tax withholding on vesting, and small director grants, which carry limited directional information. The genuine open-market signals are concentrated in a handful of filings: large purchases by Applied Digital's President and CEO/Chairman (about $5.66M and $1.01M), a cluster of small-cap insider buys at FingerMotion, Sterling Real Estate Trust, Agora, and Elite Pharmaceuticals, and a set of discretionary or 10b5-1 sales at Ciena, Teradyne, Nebius, Global-E, Sea Ltd, and Cellebrite. Sales outnumber purchases among open-market transactions, but most sales are described as executed under Rule 10b5-1 plans, which weakens their informational value. Several filings lack period-over-period, forward-looking, or capital allocation fields, so this digest relies mainly on insider transaction data rather than financial trend metrics.

50 high priority 50 total filings